CIOTechOutlook >> Magazine >> December - 2014 issue

Quintiles: Rendering Safer, Cost Effective, and Faster Data-driven Drug Development

By

Mounting data, increased cost-pressure, the patent cliff and regulations have driven the life sciences industry in the recent past. While the industry deals with petabytes to exabytes of de-identified patient data, the quality of this data is often diluted due to multiple sources and integration issues, hence affecting the overall drug development process. Additionally, explosive data growth and skyrocketing expenditure on research has created unprecedented demands for technology solutions that enable organizations to formulate cost-effective, discovery-to-market strategies. With data driving this industry today, biopharma companies have the opportunity to use this voluminous data to deliver insightful information that will lead to faster decision making, and ultimately more accessible and affordable healthcare. Quintiles, headquartered in North Carolina, USA has created a technology platform that enables seamless integration of data, therapeutic expertise and clinical trial processes that provides data transparency, optimized workflows, and real time insights into the patient, study/site and program activities. Backed by a cloud based platform, “Infosario” the company helps in delivering accurate and consistent data insights, to enhance enterprise knowledge management and improve business insights.

Articulating the differentiating factors of Quintiles, Naz Haji, CIO – Asia Pacific and Senior Vice President, Global IT, Quintiles says “Technology within Quintiles is a game changer; it’s been a focus for Quintiles for more than 30 years and is only growing in importance.Quintiles has a winning combination of domain expertise, technology leadership and data-driven processes that improve our customers’ probability of success”.

Driving Innovation into Complex and Regulated Life Sciences Industries
As drug development integrates clinical data from various drug trials, there is vast information associated with the development and marketing of new drugs. However, the current IT systems are extremely fragmented and siloed consisting of multiple and legacy systems. Making innovative use of advances in big data technologies, Quintiles Infosario is able to break down silos combining massive quantities of scientific and operational data collected during clinical development with tens of millions of real-world patient medical records and population data. Infosario takes data from multiple source systems and integrates, synchronizes and normalizes, and presents this data in near real-time.

Accelerating Drug Development through Technology Based Solutions
Patient safety is of paramount importance in the life sciences industry. Owing to the increasing demands for effective drug trials andaffordable medicines, Quintiles makes use of its technology based solutions and works closely with its biopharma customers in order to drive efficiencies to deliver better, safer and faster trials andt therapies to patients. “From faster and more focused patient recruitment to adaptive and more modern trial designs, standardized and harmonized processes and use of complex analytics and other tools, backed by Quintiles award winning Infosario®, we are focused on delivering solutions that will help accelerate the drug development process and bring medicines to market faster and at improved costs”, adds Naz.

The reporting and analytics tools embedded within Infosario® drives innovative decision making and continuously integrates operational systems and support data across multiple source systems (e.g. labs, ECG, eDC, IRT/ IVR, CTMS, Finance, HR and others) using canonical business process and reference entities.Additionally, industry standards such as CDISC are extensively used in creating the canonical definition of the master entities by Infosario.

Being a cloud based and data driven platform Infosario tracks key metrics like subject recruitment, patient data and adverse events, providing a holistic view of a study, across multi-sourced data, at any given time. By leveraging sourced data, processes and in-house expertise, it gives an immediate picture of subtle underlying trends to enable accurate analysis andquick decision-making thereby allowing investigators to make important connections to proactively address bottlenecks quickly and efficiently.

Envisioning Faster, Safer and Low Cost Drug Trials with Data Driven Technology
Given the spiraling cost of drug development and the burgeoning need of biopharmaceutical companies to make faster go/no-go decisions and reduce time to market, Quintiles has undeterringly focused on using technology to create a conducive environment for IT professionals as well as develop winning products and services. Being recognized as an award winning technology innovator, the company continues to leverage services and products that enable safer trials and aid bringing valuable new drugs to patients faster with lower development costs.

On The Deck

CXO Insights

Adaptive Identity Governance

By Sreehari Sastry, MD, India Development Center, Novell

Advisory FOR CXOs At A Crossroads To Modernize...

By Agnelo Marques, Vice President & Head Blockchain, Mphasis

Impact Of Cloud Computing In Logistics Management

By Mradul K, VP - Global & Strategy, LogiNext

Facebook